Key Insights

Highlights

Success Rate

95% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.6%

2 terminated out of 78 trials

Success Rate

95.1%

+8.6% vs benchmark

Late-Stage Pipeline

3%

2 trials in Phase 3/4

Results Transparency

0%

0 of 39 completed with results

Key Signals

95% success

Data Visualizations

Phase Distribution

38Total
Not Applicable (20)
P 1 (7)
P 2 (9)
P 3 (1)
P 4 (1)

Trial Status

Completed39
Unknown23
Withdrawn7
Active Not Recruiting3
Recruiting3
Terminated2

Trial Success Rate

95.1%

Benchmark: 86.5%

Based on 39 completed trials

Clinical Trials (78)

Showing 20 of 20 trials
NCT05123755Phase 2Recruiting

Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.

NCT05164744Recruiting

Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors

NCT04964115Active Not Recruiting

Post Acute Sequelae of COVID-19

NCT04922814Not ApplicableCompletedPrimary

Comparison for the Effect of Neuromuscular Blocking Agents Versus Sedation Alone on Severe ARDS Patients Due to COVID-19

NCT06402318Recruiting

Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine

NCT05765396Active Not Recruiting

SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies

NCT04896853Phase 1Active Not RecruitingPrimary

Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®

NCT04979884Phase 3CompletedPrimary

Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital

NCT05470907CompletedPrimary

Registry for Hemoperfusion of Covid-19 ICU Patients

NCT04930874Not ApplicableTerminatedPrimary

Cerebral Autoregulation and COVID-19

NCT05097677Completed

Follow-up of Covid-19 Long Term Sequelae

NCT05212662Phase 2Withdrawn

Study of Cysteamine-pantetheine Disulfide (TTI-0102) in Mild to Moderate COVID-19

NCT04896866Not ApplicableCompleted

Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP)

NCT05387278Phase 1SuspendedPrimary

Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)

NCT05954351CompletedPrimary

PRactice of Ventilation and Adjunctive Therapies in COVID-19 Patients.

NCT05798260WithdrawnPrimary

T-Cell Mitochondrial Respiration Response to Ketone Monoester Supplement in Healthy Volunteers and COVID-19

NCT05330845Not ApplicableTerminatedPrimary

Interleukine 6 (IL6) Assay for Predicting Failure of Spontaneous Breathing in Patients With COVID-19 Acute Respiratory Distress Syndrome

NCT05780255CompletedPrimary

Quality of Life 1y and 2 y After VV-ECMO for COVID-19

NCT05028244Not ApplicableCompleted

Evaluation of Serial Ultrasound Screening in ICU COVID-19 Patients

NCT06311448CompletedPrimary

Personalized Targeted Immunomodulation in COVID-19 ARDS

Scroll to load more

Research Network

Activity Timeline